Erlotinib
NDC 68382-915, Erlotinib, tablet, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 68382-915
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213065
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68382-915 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERLOTINIB HYDROCHLORIDE150 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68382-915-06 | 68382091506 | 30 TABLET in 1 BOTTLE (68382-915-06) |
| 68382-915-16 | 68382091516 | 90 TABLET in 1 BOTTLE (68382-915-16) |
| 68382-915-84 | 68382091584 | 3 BLISTER PACK in 1 CARTON (68382-915-84) / 10 TABLET in 1 BLISTER PACK (68382-915-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c35e019d-ec34-4e61-9400-a7ae7913e025
Use it
Look up 68382-915 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68382-915 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68382-915. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.